Lung Cancers Terminated Phase 2 Trials for Retaspimycin (DB05626)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01228435IPI-504 in NSCLC Patients With ALK TranslocationsTreatment